This announcement is a separate document:
Argenica Therapeutics Ltd: ARG-007 Reduces Effects of TBI in Preclinical Study
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.